Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Puma Biotechnology (PBYI) has a market cap of $0.14 billion USD. According to our data, Puma Biotechnology is ranked No.7304 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $0.14 B |
-5.23%
|
| Dec 31, 2024 | $0.15 B |
-29.56%
|
| Dec 29, 2023 | $0.21 B |
2.36%
|
| Dec 30, 2022 | $0.21 B |
39.14%
|
| Dec 31, 2021 | $0.15 B |
-70.37%
|
| Dec 31, 2020 | $0.50 B |
17.26%
|
| Dec 31, 2019 | $0.43 B |
-57.00%
|
| Dec 31, 2018 | $1.00 B |
-79.41%
|
| Dec 29, 2017 | $4.85 B |
221.99%
|
| Dec 30, 2016 | $1.51 B |
-60.84%
|
| Dec 31, 2015 | $3.85 B |
-58.58%
|
| Dec 31, 2014 | $9.29 B |
82.82%
|
| Dec 31, 2013 | $5.08 B |
452.16%
|
| Dec 31, 2012 | $0.92 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Genmab
GMAB
|
$12.54 B |
-0.000 M
|
Denmark
|
 Exelixis
EXEL
|
$9.97 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.27 B |
0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
USA
|
 Array Technologies
ARRY
|
$0.66 B |
0.000 M
|
USA
|
 Agios Pharmaceuticals
AGIO
|
$1.58 B |
0.000 M
|
USA
|
 Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
Canada
|
 MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
USA
|
 Syndax Pharmaceuticals
SNDX
|
$0.99 B |
0.000 M
|
USA
|
 Karyopharm Therapeutics
KPTI
|
$42.42 M |
-0.000 M
|
USA
|
| Market Cap | = | PBYI Stock Price | * | PBYI Shares Outstanding |
| = | $2.86 | * | 49.61 M | |
| = | $0.14 B |